Literature DB >> 2137041

Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat.

D de la Bastie1, D Levitsky, L Rappaport, J J Mercadier, F Marotte, C Wisnewsky, V Brovkovich, K Schwartz, A M Lompré.   

Abstract

The reduction in Ca2+ concentration during diastole and relaxation occurs differently in normal hearts and in hypertrophied hearts secondary to pressure overload. We have studied some possible molecular mechanisms underlying these differences by examining the function of the sarcoplasmic reticulum and the expression of the gene encoding its Ca2(+)-ATPase in rat hearts with mild and severe compensatory hypertrophy induced by abdominal aortic constriction. Twelve sham-operated rats and 31 operated rats were studied 1 month after surgery. Eighteen animals exhibited mild hypertrophy (left ventricular wt/body wt less than 2.6) and 13 animals severe hypertrophy (left ventricular wt/body wt greater than 2.6). During hypertrophy we observed a decline in the function of the sarcoplasmic reticulum as assessed by the oxalate-stimulated Ca2+ uptake of homogenates of the left ventricle. Values decreased from 12.1 +/- 1.2 nmol Ca2+/mg protein/min in sham-operated rats to 9.1 +/- 1.5 and 6.7 +/- 1.1 in rats with mild and severe hypertrophy, respectively (p less than 0.001 and p less than 0.001, respectively, vs. shams). This decrease was accompanied by a parallel reduction in the number of functionally active CA2(+)-ATPase molecules, as determined by the level of Ca2(+)-dependent phosphorylated intermediate: 58.8 +/- 7.4 and 48.1 +/- 13.5 pmol P/mg protein in mild and severe hypertrophy, respectively, compared with 69.7 +/- 8.2 in shams (p less than 0.05 and p less than 0.01, respectively, vs. shams). Using S1 nuclease mapping, we observed that the Ca2(+)-ATPase messenger RNA (mRNA) from sham-operated and hypertrophied hearts was identical. Finally, the relative level of expression of the Ca2(+)-ATPase gene was studied by dot blot analysis at both the mRNA and protein levels using complementary DNA clones and a monoclonal antibody specific to the sarcoplasmic reticulum Ca2(+)-ATPase. In mild hypertrophy, the concentrations of Ca2(+)-ATPase mRNA and protein in the left ventricle were unchanged when compared with shams (mRNA, 93.8 +/- 10.6% vs. sham, NS; protein, 105.5 +/- 14% vs. sham, NS). in severe hypertrophy, the concentration of Ca2(+)-ATPase mRNA decreased to 68.7 +/- 12.9% and that of protein to 80.1 +/- 15.5% (p less than 0.001 and p less than 0.05, respectively), whereas the total amount of mRNA and enzyme per left ventricle was either unchanged or slightly increased. The slow velocity of relaxation of severely hypertrophied heart can be at least partially explained by the absence of an increase in the expression of the Ca2(+)-ATPase gene and by the relative diminution in the density of the Ca2+ pumps.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137041     DOI: 10.1161/01.res.66.2.554

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  56 in total

1.  Cardiac expression of Gal4 causes cardiomyopathy in a dose-dependent manner.

Authors:  Petra E M H Habets; Danielle E W Clout; Ronald H Lekanne Deprez; Marian A van Roon; Antoon F M Moorman; Vincent M Christoffels
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  Matrix elasticity regulates the optimal cardiac myocyte shape for contractility.

Authors:  Megan L McCain; Hongyan Yuan; Francesco S Pasqualini; Patrick H Campbell; Kevin Kit Parker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-28       Impact factor: 4.733

3.  Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.

Authors:  K C Chang; V M Figueredo; J H Schreur; K Kariya; M W Weiner; P C Simpson; S A Camacho
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  Myocardial Ca-sequestration failure and compensatory increase in Ca-ATPase with congestive cardiomyopathy: kinetic characterization by a homogenate microassay using real-time ratiometric indo-1 spectrofluorometry.

Authors:  P J O'Brien; H Shen; J Weiler; M Mirsalimi; R Julian
Journal:  Mol Cell Biochem       Date:  1991-03-27       Impact factor: 3.396

Review 5.  Cellular mechanisms of arrhythmogenic cardiac alternans.

Authors:  Kenneth R Laurita; David S Rosenbaum
Journal:  Prog Biophys Mol Biol       Date:  2008-02-15       Impact factor: 3.667

6.  Influence of different culture conditions on sarcoplasmic reticular calcium transport in isolated neonatal rat cardiomyocytes.

Authors:  R Vetter; M Kott; W Schulze; H Rupp
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  A novel E box/AT-rich element is required for muscle-specific expression of the sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene.

Authors:  D L Baker; V Dave; T Reed; S Misra; M Periasamy
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

8.  Assessment of intra-SR free [Ca] and buffering in rat heart.

Authors:  T R Shannon; D M Bers
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

9.  Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes.

Authors:  Mingming Zhao; Giovanni Fajardo; Takashi Urashima; Joshua M Spin; Sara Poorfarahani; Viswanathan Rajagopalan; Diem Huynh; Andrew Connolly; Thomas Quertermous; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

10.  Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.

Authors:  M Sulaiman; M J Matta; N R Sunderesan; M P Gupta; M Periasamy; M Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.